C
Cruinn Diagnostics
Leading supplier of clinical diagnostics, laboratory consumables, and calibration testing for efficient and accurate results
About Cruinn Diagnostics
Cruinn Diagnostics operates in the clinical diagnostics and laboratory equipment market, providing a comprehensive range of products and services to healthcare facilities, research institutions, and laboratories. The company offers solutions such as Covid-19 Rapid Antigen Tests, Point of Care CBC Analyzers, and heavy-duty autoclaves like the Rodwell Ambassador. Their product portfolio also includes laboratory consumables, calibration, and testing services. Cruinn Diagnostics serves a diverse client base, including hospitals, clinics, and research labs, ensuring they have access to high-quality diagnostic tools and equipment. The business model revolves around direct sales and customer support, with a strong emphasis on technical assistance and efficient order processing. Revenue is generated through the sale of diagnostic products, laboratory equipment, and consumables, as well as through calibration and testing services.
Source: Dealroom company dataAt a glance
- Founded
- 1998
- Headquarters
- Dublin, Ireland
- Sector
- Health
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
MML Growth Capital Partners Ireland
Waterland Private Equity
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cruinn Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cruinn Diagnostics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.